bluebird bio (BLUE)
(Real Time Quote from BATS)
$0.49 USD
+0.02 (4.21%)
Updated Sep 23, 2024 11:04 AM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Bluebird Bio (BLUE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.11 | $6.00 | $1.00 | 561.70% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Bluebird Bio comes to $3.11. The forecasts range from a low of $1.00 to a high of $6.00. The average price target represents an increase of 561.7% from the last closing price of $0.47.
Analyst Price Targets (9 )
Broker Rating
Bluebird Bio currently has an average brokerage recommendation (ABR) of 2.73 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 2.73 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, three are Strong Buy, representing 27.27% of all recommendations. A month ago, Strong Buy represented 27.27%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 7 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.73 | 2.73 | 2.73 | 2.58 | 2.62 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | Cantor Fitzgerald & Co | Eric Schmidt | Hold | Hold |
8/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/15/2024 | Robert W. Baird & Co. | Jack K Allen | Strong Buy | Strong Buy |
8/15/2024 | Not Identified | Not Identified | Hold | Hold |
8/14/2024 | William Blair | Sami Corwin | Hold | Hold |
7/2/2024 | SVB Securities | Mani Foroohar | Hold | Hold |
6/30/2024 | Goldman Sachs | Salveen Richter | Strong Sell | Strong Sell |
3/27/2024 | Wells Fargo Securities | Yanan Zhu | Hold | Hold |
3/5/2024 | Not Identified | Not Identified | Moderate Sell | Moderate Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.73 |
ABR (Last week) | 2.73 |
# of Recs in ABR | 11 |
Average Target Price | $3.11 |
LT Growth Rate | 26.00% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.48 |
BLUE FAQs
bluebird bio, Inc. (BLUE) currently has an average brokerage recommendation (ABR) of 2.73 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms.
The average price target for bluebird bio, Inc. (BLUE) is $3.11. The current on short-term price targets is based on 6 reports.
The forecasts for bluebird bio, Inc. (BLUE) range from a low of $1 to a high of $6. The average price target represents a increase of $561.70 from the last closing price of $.47.
The current UPSIDE for bluebird bio, Inc. (BLUE) is 561.70%
Based on short-term price targets offered by nine analysts, the average price target for Bluebird Bio comes to $3.11. The forecasts range from a low of $1.00 to a high of $6.00. The average price target represents an increase of 561.7% from the last closing price of $0.47.